Chinese Journal of Parasitology and Parasitic Diseases

About Journal

The Chinese Journal of Parasitology and Parasitic Diseases (CJPPD) (ISSN: 1000-7423) is the academic journal for parasitology and parasitic diseases in China published by National Institute of Parasitic Diseases (NIPD), Chinese Center for Disease Control and Prevention (China CDC) and sponsored by National Disease Control and Prevention Administration，P. R. China. It was originally named as Parasitology & Parasitic Diseases in 1983 and renamed as Chinese Journal of Parasitology and Parasitic Diseases in 1987. It has been selected as one of the serial journals of the Chinese Preventive Medicine Association since 1992. It has changed from quarterly to bimonthly since 1997. The Chinese Preventive Medicine Association has become the first organizer of the journal since 1999.

At the time of its inception, the journal was the only academic journal for parasitology and parasitic diseases in China. Qian Xinzhong, the minister of Chinese Ministry of Health wrote the inaugural article of journal and Professor Wu Zhengjian inscribed the title of journal. The goal of journal is to report the original research and control experience in parasitology and tropical medicine, introduce new theories, new technologies and new progress, improve the professional level of professionals and promote the scientific research of parasitic disease prevention and academic exchanges at home and abroad.

The journal currently has 4 fixed columns include monographs, reviews, research briefs and case reports, and multiple non-fixed columns such as academic contention, expert forums, new horizons, information exchange, teaching and research. The readers are mostly those scholars involved in the scientific research, disease prevention and control, clinical workers and medical teaching for parasitology and parasitic diseases.

In view of the academic level and publication quality of this journal, it has been issued to or established the journal exchange program in more than 27 countries or districts around the world. It is one of the journals selected to display in the reading room of the WHO library in Geneva and has become an important window for the academic exchange of this subject.

Since its inception, the journal has been listed by the Chinese Scientific and Technical Papers and Citations Database (CSTPCD）(1987), the Chinese Science Citation Database (CSCD)(1989), and the Chinese Academic Journals of Comprehensive Evaluation Database (CAJCED) ( 2002) as the source journal of statistical sources (all indexed in the year when the database was created).

Since the first Chinese S & T Journal Citation Reports issued by the Institute of Scientific and Technical Information of China (ISTIC) in 1998, this journal has been selected as the Outstanding Scientific & Technological Journal of China. The Impact Factor of journal was 0.324 in 1997, rise to 1.455 in 2022 which remains high , and top of Chinese Basic Medical Research Journals.

The journal was selected as the Excellent Database of Chinese Scientific and Technological Journals in 2004, and also granted a Certificate among 100 Outstanding Academic Journals of China in 2009. It was selected as the second, third and fourth Chinese Excellent Scientific and Technological Journals in 2010, 2013 and 2017 (which is the first time to select the top 300 domestic journals in 2008). The journal was also awarded as the Excellent International Impact Academic Journal of China during 2014-2017. Since 2011, it has been selected as the RCCES Chinese authoritative academic journal (A +).

Since the journal was selected as the Core journal of Chinese Basic Medical Research Journals in A Guide to the Core Journals of China 1992 edition (1st edition) in 1992, it has been continuously selected in the 2023 edition (10th edition).

The journal has been indexed by Medline since 1987（as of June 2017）, and then has been indexed by Scopus（1987-1995,1998-2016,July 2，2021-）, Embase（1987-1995,1998-2016,2021）、EBSCO（since 2014）、JSTChina（since 2007）、CABI（since 2003）、Zoological Record（since 1998）、WPRIM（since 1983）,Ulrichsweb (since 2009）, and Google Scholar.

With the leadership and support of the previous editorial committees and the joint efforts of the editorial department, this journal was awarded as the Excellent Journal of Serial Journals of Chinese Preventive Medicine Association for the years of 1992, 1994, and the First-Class Excellent Journals by China Association of Preventive Medicine for the years of 1996, 2000, 2005, 2007, 2009, 2011, 2013, 2015, 2017,2019. The excellent award was also granted to CJPPD by the China Ministry of Public Health in 2005 and 2013, the Excellent Journal in Eastern China in 2009 and 2013. The journal won the Shanghai Scientific and Technological Journal Editing and Quality Excellence Award in 2007, and the Shanghai Scientific and Technological Journal Reading Excellence Award in 2010.

In 2006, the journal established a periodical website (http://www.jsczz.cn) and a database of back issues (it has been traced back to the time when it was first published in 1983). In the same year, it introduced a periodical collection and editing system, which realized online submission and review of articles, and achieved electronic management of manuscripts.

In 2012, the journal which is awarded as the Outstanding Scientific & Technological Journal of China has been selected as the source journal of the Top Articles from Outstanding S & T Journals of China (F5000) project, and many high-cited papers were selected to enter F5000 every year.

In 2015, the journal cooperated with the China National Knowledge Infrastructure (CNKI) and launched the Priority Online Digital Publishing service, that means the journal was published on the China National Knowledge Infrastructure (CNKI) before being published in paper, and was available for retrieval and citation, which greatly shortened the communication time lag of published articles.

In 2018, the journal signed the CAJ-N Network First Academic Journal Cooperative Publishing Agreement with the China National Knowledge Infrastructure (CNKI), which also reflects the priority of online publishing and the protection of right to issue.

In 2016, the journal applied the WeChat Official Account (CJPPD_NIPD_ChinaCDC) and established the WeChat public platform, which means the dynamic information, current journals and back issues databases can be accessed through mobile terminals. Since then, the journal has embarked on the road of new media publishing.

Editorial office information:

Address: National Institute of Parasitic Diseases (NIPD), Chinese Center for Disease Control and Prevention (China CDC)
No. 207, Ruijin Second Road, Huangpu District, Shanghai, 200025

Tel:
021-54562376 or 54653513
021-64377008 × 1305 

E-mail:
zgjsczz@nipd.chinacdc.cn (new), 
zgjsczz@vip.163.com

Web:
http://www.jsczz.cn
WeChat Official Account: CJPPD_NIPD_ChinaCDC

Editorial Board

• » Newly Invited Young Members of Editorial Board（2023） [2024-07-18]
• » Newly Invited Overseas Members And Young Members of Editorial Board（2020） [2020-11-11]
• » The Fifth Editorial Board Members （2018） [2021-07-28]

Author Instructions

The Chinese Journal of Parasitology and Parasitic Diseases is administered by the National Health Commission of the People′s Republic of China. As the official Journal of the Chinese Preventive Medicine Association and National Institute of Parasitic Disease-Chinese Center for Disease Control and Prevention, we are publishing manuscripts on parasitology and parasitic diseases. In particular, we are dedicated to publishing scientific research on parasitology and experience in the control of parasitic diseases. Our goal is to introduce new hypotheses, technologies and progress in the field to promote academic exchange and to advance scientific research and disease prevention and control.

We publish research articles, reviews, research notes and case reports on a regular basis, and we would also consider commentaries, perspectives, correspondences and debates on an individual basis.

1  Requirement

The manuscripts should be scientifically sound, logical and of theoretical and/or practical significance, and should have clear arguments, reliable data, reasonable structure, and accurate and concise expression.

1.1  Title

The title should be accurate, concise, and easy to search and read. The title should reflect and summarize the full text and highlight the theme. Use of punctuation in the title should be avoided. The tile should be no more than 20 Chinese characters. Use of English abbreviations should be minimised. 

1.2  Authors, affiliations and funding

Names of all authors, affiliations, cities, postal codes and countries should be listed. The corresponding author should be marked with a superscript ‘*’. Authors’ names should be listed with Pinyin (romanisation system for standard Chinese). Each letter of the surname should be capitalized, and only the first letter of the first name should be capitalized; a hyphen should be used between each Chinese character in first names, for example, WU Wei-ping. Only one author should be designated as the first author or corresponding author. Co-first authors or co-corresponding authors are not allowed. For national or provincial funding, the project name and grant code should be provided. Authors, affiliations and funding should be provided in both English and Chinese, and consistency between Chinese and English should be ensured.

1.3  Abstract

For research articles, a structured abstract is required, including objectives, methods, results and conclusions. The objective should include one or two sentences that accurately explain the research purpose. The methods for epidemiological and field studies should specify the time, location, sampling method or data source, analysis methods and statistical analysis methods; the methods for basic and laboratory research should specify the experimental design, methods, sample acquisition time, testing indicators and statistical analysis methods. The results should be described in the same order presented in the methods; the main data should be listed first and followed by statistical analysis. The same number of decimal places should be used for the same set of data/results. Test values and P values should be provided for statistical analysis.

The conclusion should be in accordance with the purpose and should be based on the results. Conclusions not supported by concrete data in the results should not be included.

A reporting abstract is applicable for review articles and research notes; it should summarize the content reported in the manuscript and the main results and conclusions, and should help readers decide whether to read the full text.

1.4　　Keywords

Three to five Chinese and English keywords should be included, with disease or insect names first, followed by content or methods. Medical subject headings (MeSH) and MeSHAAL should be followed.

1.5  Format of manuscripts

1.5.1  Research article

1.5.1.1  Introduction

In this section, the background--that is, what has been done, what problems still exist and the purpose of the study--should be introduced. Data and conclusions should not be included.

1.5.1.2  Materials and methods

The criteria for the methods section of the abstract apply. However, more details should be provided as follows:

For epidemiological and field studies, a clear description of the time, location, population (age range), source of data, sampling method, analysis methods and index, quality control and statistical analysis should be provided. For basic and laboratory research, a clear description of the experimental grouping, processing methods, sample/sample collection time, testing and statistical methods should be provided.

If applicable, methods of randomization should be described. Statistical methods--such as statistical research design, expression and description of data, selection of statistical analysis methods, and interpretation and expression of statistical results--should be described in as much detail as possible. For research involving human participants, ethics approval documents and informed consent forms should be included. For studies reporting animal experiments, a statement should be included describing whether the national regulations governing the management and use of experimental animals and the relevant institutional guidelines were complied with. Results should not be included in the materials and methods. Standard Chinese names should be used for reagents. If manufacturers of reagents and instruments are not domestic, the country of origin should be provided. For domestic manufacturers, the full name of the company should be provided.

1.5.1.3  Results

The criteria for the results section of the abstract apply. However, more details should be provided. The results should be described in the same sequence as the methods section. The main data should be listed first and followed by comparisons. The same number of decimal places should be used for the same set of data/results. Test values and P values should be provided for statistical analysis. Discussion topics should not be included in the results.

Note: ① Results for immunology and molecular biology should be validated. Results involving only cloning and expression analysis will be publishable only as research notes.  ② Molecular biological identification results must be provided for any ‘new species’ found in the study on the basis of morphological identification; otherwise, the manuscript will not be considered.

1.5.1.4  Discussion

The discussion should be based on the results or comparison with relevant studies. The application value or importance should be described. Descriptions of the methods, results or background should not be repeated in the discussion.

1.5.2  Review article

In general, a review article should be a comprehensive discussion of a certain topic that is based on published works; it should include analysis and discussion, describe the state of the art and provide future perspectives. Solely summarizing previous results is not sufficient. For narrative review articles, subheadings of the same level are parallel to each other. English should be translated and restructured by following Chinese grammar. Use of abbreviations should be minimised. Terminologies should be made consistent throughout the manuscript. References should be up to date and should include mainly publications within the previous 5 years. A minimum of 35 references should be cited.

1.6  Figures and tables

Overlap of the results shown or described in tables/figures and the text should be minimised. The major data should be first cited in the main text, and followed by figures and tables. Tables should be concise and should generally comprise three (horizontal) line tables without vertical lines. In figures, the horizontal and vertical axes and legends should be clearly shown, and the text annotation should be editable and placed outside the image. For pathological images, the main pathological changes must be briefly described, and the target should be highlighted with arrows. Figures and tables (including titles and legends) of research articles must be provided in both Chinese and English, and consistency should be ensured. In table/figure legends, statistical analysis results should be provided with a, b, c, etc., together with notes in both Chinese and English (do not use *, **, ***). Images should be of sufficient resolution (over 300 pixels). In addition to being inserted in the Word file, each figure should be provided to the editorial office in ‘JPG’ or ‘TIF’ format for typesetting purposes.

1.7  Nomenclature

Please consult the vocabulary or dictionary published by the People′s Medical Publishing House and Science Press for correct terminologies. Species names should be written as italicized Latin names at their first occurrence in the text, for example, Echinococcus granulosus. Full technical terms are generally used in the main text. However, if a full term is long and is repeated more than five times, abbreviations may be used; full terms in Chinese should be defined where the abbreviation first appears, and the English full name and abbreviation should be included in parentheses. For example, if ‘RNA interference (RNAi)’ is defined at first mention, the abbreviation ‘RNAi’ can be used thereafter. For commonly used abbreviations, such as DNA, RNA, PCR, RT-PCR, ELISA and AIDS, abbreviations can be used directly without definition. The same terminology should be used for the same specie/agent throughout.

1.8  Units and italics

China statutory measurement units should be used. The unit name and unit symbol should not be used in a mixed manner. To indicate the relationships among dosage, mass and time, mg/(kg·d) should be used instead of mg/kg/d. Ranges should be expressed with ‘~’ in Chinese (‘-’ is used in English), such as 18% ~ 28%, 3 × 10⁹ ~ 5 × 10⁹ or (3 ~ 5) × 10⁹. Tolerance may be expressed as (73.6 ± 2.3) mg/m3. Symbols commonly used in statistics (for example, n, χ², P, t and x ± s) should be italicized. Symbols of quantity should be in italics; for example, the symbol of absorbance (formerly called optical density) is an italicized A. For all pressure measurements involving human and animal bodies, either mm Hg or cm H₂O may be used. However, the conversion coefficient of mm Hg or cm H₂O to kPa (1 mm Hg = 0.133 kPa, 1 cm H₂O = 0.098 kPa) should be indicated at first mention in the text. The concentration unit M should be replaced with mol/L, for example, 5 mol/L instead of 5 M. Centrifugal units in rpm should be converted to units of centrifugal force, g, for example, 12 000 × g for 5 min. The relative molecular mass (M_r) of a protein should not be expressed in kDa; for example, use 20 000 instead of 20 kDa. Days, hours, minutes and seconds should be expressed as d, h, min and s when used as time units, for example, 5 d, 10 h, 30 min and 20 s. Chinese characters should not be used as units. A space should separate numerals and units, for example, 5 mol/L. The symbols +, -, ±, ×,﹤and = should be separated from adjacent text with one space before and after, for example, 419.00 ± 60.86 and P < 0.05. For numbers with four or more significant figures, a space should be placed every three digits before and after the decimal point, for example, 20 000, 0.235 48.

1.9  References

Original papers should be cited (and translations, summaries of an original paper, reprints or internal documents should not be used). References should be numbered in the order in which they appear in the main text. In the main text, references should be indicated by superscript numbers in square brackets. References must be cited sequentially. Please ensure consistency between the citations in the main text and the reference list. We suggest using software, such as SFSOFTWARE or Medlive, to check the references.

1.9.1  Journals

References should be formatted as follows:

[number] Author. Title [J]. Publication name (English abbreviations should be in accordance with Index Medicus), year, volume (issue): first page-end page. (The first to third authors should be included, followed by ‘et al.’ in cases with more than three authors, the volume and issue should be provided.)

Example:

[1] Zhou XN, Chen J, Sheng HF, et al. Comments on the writing points of english medical research papers[J]. Chin J Parasitol Parasit Dis, 2018, 36 (2): 153-155, 160

[2] Marques J, Cardoso JCR, Felix RC, et al. Fresh-blood-free dish for commanding malaria mosquito vectors[J]. Sci Rep, 2018, 8 (1):17807

1.9.2  Books

[number] authors (or editors). Title[M]. Edition number. Place of publication: Publisher, Year: first page-end page.

Example:

[1] Wu GL. Human parasitology[M].  3rd edition. Beijing: People’s Medical Publishing House, 2005: 687-696.

1.9.3  Book chapters

Example:

[2] Wang YZ. Clonorchis sinensis[M]// Zhao WX. Human Parasitology. 2nd edition. Beijing: People’s Medical Publishing House, 1994: 521-538.

2  General information

2.1 Submission, editorial assessment, peer review, editorial board discussion and online publication

2.1.1 Submission

Only online submissions will be received (submission website: http://www.jscz.cn).

Register (provide mobile phone numbers of the first author and corresponding author) → obtain user name and password → login → submit online. The editorial office never authorizes any third parties to perform manuscript submission, given that many fake submission websites exist on the internet. Please take extra caution and use only our official submission website. Authors can log into the submission system with a user name and password, then further track manuscript status online.

2.1.2  Editorial assessment

After successful submission, preliminary editorial assessment will be completed within 1 week. Manuscripts that do not meet journal requirements will be rejected or recommended for transfer if they are outside the scope of this journal, if they present preliminary results or are review articles without novel perspectives.

2.1.3  Peer review

After editorial assessment, manuscripts will be sent to two experts for peer review. If one of the reviewers recommends ‘reject’ or ‘not suitable for publication in this journal’, the editorial office will seek a third opinion. If more than two reviewers recommend ‘reject’, the editorial office will reject the manuscript.

Note: Peer reviewers selected by editorial offices are all experts with relevant research background. They are not the authors or members of the author’s research group, and they have no competing interests with the authors.

2.1.4  Editorial board discussion

According to the peer review reports, the editors will send decision letters to authors via the submission system. Revised research articles are discussed at editorial board meetings held in Shanghai, which are organized by the editorial office bi-monthly. On the basis of two or more peer reviewers’ reports, editors discuss the scientific aspects of the manuscript and provide comments to authors for further revision. Final decisions (reject/accept), as well as the article type, will be determined in editorial board meetings.

2.1.5  Online publication

This journal has signed the ‘CAJ-N Online Academic Journal Co-publishing Agreement’ with CNKI. All manuscripts will be published online on the CNKI platform after it is finalized.

2.1.6  Miscellaneous

As of 2019, DOI format is applicable and is added to the front page of each published manuscript. In addition, a brief introduction of authors (authors should provide the relevant information), publication date and URL are added.

2.2  Conflicts of interest, human and animal rights, informed consent and ethical statements

The journal complies with the guidelines of the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje. org/). Authors, peer reviewers, editors and the editorial staff are all required to submit statements declaring any conflicts of interest that may exist in the peer review and publication process. For experiments involving human participants, ethics approval documents describing informed consent (or, for minors, informed consent obtained from guardians) must be included. For studies reporting animal work, authors should state whether national regulations governing the management and use of experimental animals and relevant institutional guidelines were complied with. For more information, please refer to the International Association of Veterinary Editors: Consensus author guidelines on animal ethics and welfare for editors (http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors).

As of 2019, the following statements are mandatory for all submissions: author information, ethics approval documents and informed consent to participate (for research involving human participants, informed consent regarding medical ethics must be included), consent to publish (provide ‘Authorization of exclusive right to publish’; the exclusive right to use the manuscript belongs to the editorial office of this journal and the Chinese Preventive Medicine Association), availability of data and materials, conflicts of interests, funding, and authors’ contributions and acknowledgments. If some of the above mentioned statements are not applicable, please state ‘not applicable’ under the corresponding heading. Copies of other relevant materials--such as funding approval documents, ethics approval documents, informed consent forms and authorization of exclusive right to publish--should be compressed and uploaded to the submission system under the category of ‘Copyright Agreement’.

2.3  Authorship

　　Only one author may be listed as the first author or as the corresponding author. Individuals who contributed to the work but who are not qualified as authors may be acknowledged in ‘Acknowledgements’. For any addition/removal of authors after submission, a written explanation listing all new authors and including the signatures of the first author and corresponding author should be scanned and sent to editorial office. Otherwise, the authorship change will not be accepted.

2.4  Author responsibilities

Authors take full responsibility for their manuscript. According to the relevant copyright law, the editorial office has the right to edit the original manuscript. However, any amendments related to changes in content are sent to the authors for consideration. Drafts after typesetting and the final drafts are sent to authors for proofreading through the submission system. Authors should read through the draft carefully (including texts, figures and tables) and respond to the suggestions raised by the editors.

2.5  Page charges

Page charges are applicable for accepted manuscripts. A notification with more details is delivered to authors from the submission system.

Only bank transfers will be accepted (for transfer please indicate: ZG-page charges and name of the first author). The required information for transfer is as follows:

Name: Chinese Center for Disease Control and Prevention, National Institute of Parasitic Disease

Taxpayer Identification Number: 310101425012891

Address: No. 207, Ruijin Er Road, Huangpu District, Shanghai

Tel: 021-64664322

Bank and Account No.: ICBC (Industrial and Commercial Bank of China), Shanghai Ruijin Er Road Sub-branch, 1001253709026400233

2.6  Push notification service after publication

The editorial office offers editorial board members/peer reviewers the table of contents and abstracts by push notifications through email.

2.7  Offprints

The first author (by default) will, at no cost, receive two print copies of the current issue after publication. The editorial board member/peer reviewers will, at no cost, receive one print copy of the current issue. The cover and table of contents of the current issue and the manuscript may be downloaded from the official website of the journal (full text could also be downloaded from CNKI).

3  Editorial contact information

National Institute of Parasitic Disease, Chinese Center for Disease Control and Prevention

No. 207, Ruijin Er Road, Huangpu District, Shanghai 200025, China

Editorial office of ‘Chinese Journal of Parasitology and Parasitic Diseases’

Telephone: 021-54562376, 021-64377008 ×1305

E-mail: zgjsczz@nipd.chinacdc.cn

http://www.jsczz.cn

WeChat: CJPPD_NIPD_ChinaCDC

Publishing Ethics

In order to further strengthen the professional ethics of authors, reviewers and editors, and to improve the publication level of journals, the editorial department refers to relevant publication ethics standards such as the International Publication Ethics Committee (COPE) and the International Medical Journal Editing Committee (ICMJE), and according to the actual situation of journal publication, the publishing ethics and ethics standards for the editorial department are as follows:

I. The responsibility of Editorial Board

1. Responsibility to Authors

(1) The editorial board should effectively arrange peer reviews, make editorial decisions, and communicate with authors in a clear and constructive manner. Every manuscript will be treated equally according to the principles of double-blindness, fairness, justness and objectiveness.

(2) The editorial decision should be based on the correlation between the content of the paper and the journal, the originality and quality of paper and the contribution to important issues of paper, and should not be challenged by commercial interests, personal relationships, negative reports and authority.

(3) If there is competition, cooperation or other related conflicts of interest with authors and institutions, the editor should take the initiative to avoid processing the manuscript.

(4) Recommend and refusal reviewers proposed by the author should be verified, and the reasons should be determined before deciding whether to adopt the opinions. The editor should avoid editing, reviewing, and finalizing the manuscripts of authors with friends, teachers, students, and relatives.

(5) The content of the manuscript is kept confidential, and the author's research results cannot be used in violation of regulations.

(6) The editor is responsible for formulating, implementing and regularly reviewing the policies about the ethical issues or misconduct of authors.

(7) Authors are supported to submit integrity support materials related to academic research.

2. Responsibility to Reviewers

(1) The editorial board should pay attention to protecting the personal information and legitimate rights and interests of reviewers. Reviewers are required to keep the manuscript and related materials strictly confidential, and should not publicly discuss the author's research before it is officially published.

(2) Manuscripts should be assigned for review according to the reviewer ’s research field.

(3) Reviewers are required to be alert to potential conflicts of interest with authors and avoid them in a timely manner.

(4) Reviewers are allowed to have enough time to complete the review.

(5) The opinions of reviewers should be respected, if the authors have objections, allow them to file an appeal.

(6) The editorial board encourage academic controversy and allow readers to submit comments, questions or criticisms about published papers. Author is responsible for responding to this and cooperating with the editorial department to respond to any queries about data or other information.

3. Editor's Responsibility to Readers and the Scientific Community

(1) Editors should review all authors and take responsibility for the content of the final manuscript or for the parts they contributed.

(2) Editors should have journal integrity, for example, correct mistakes, clearly identify and distinguish between different academic misconducts, and correct, corrigenda, withdraw papers or supplement data.

(3) Editors should participate in all relevant potential conflicts of interest in the review or determine that there are no conflicts of interest.

(4) After publication, editors should retain the management of the original submissions and related processing traces in the editing and editing system, and including scanning the review manuscripts at all levels (Such as English proofreading manuscript, editorial board director review manuscript, executive director final review manuscript, etc.) and electronic filing.

(5) Domestic and international publishing standards should be followed during the publishing process.

II. Editor's Rights

1. Based on the reliability of research and the importance to journal readers, editorial decisions should be able to freely express critical and responsible opinions on medical issues without fear of retaliation.

2. The journal helps editors formulate and maintain editorial policies through an independent editorial board.

3. If necessary, the editor can seek advice for decision-making and controversial views from multiple parties, such as reviewers, editorial staff, editorial board members, and readers.

4. If legal issues arise, the confidentiality of authors and reviewers (including review comments) should be maintained (with the exception of informed consent).

III. Publication and Copyright

1 According to the Copyright Law of the People's Republic of China and the specific circumstance of this journal, no further notification received by author 3 month later after receiving the receipt from the editorial board for a successful manuscript submission indicating that the manuscript is still in evaluation. If author is going to send this manuscript to other journal, please contact the editorial board and make no multi contribution. If multi-contribution is discovered, the manuscript to this journal will be send back promptly. Once the re-publication of a manuscript on other journal is discovered, a declaration about the re-publication will be issued by the editorial board, and any contribution of the author will be refused within 2 years.

2 When the author submits a manuscript, a certificate of authorization for exclusive right to use of the thesis or copyright protocol will be signed by author in his (her) own hand, and it will be uploaded to the system with the original manuscript.

3 When a manuscript is decided to publish, page fee will be charged according to the number of finalized manuscript words, and a one-off payment of remuneration and related copyright use fee will be made for author. The published thesis will be included by authoritative databases both at home and abroad.

4 Plagiarism and fraudulent data are forbidden to avoid any academic misconduct issues.

5. This journal has the right to modify the text of the manuscript, but it will not modify the core data and content in the manuscript.

IV. Academic Misconduct

Academic misconduct includes but is not limited to: fabricate data, forge data (such as deceptive image) and plagiarism. If the author is questioned or discovered the academic misconduct of submitted or published papers, the journal will usually initiate the relevant procedures of COPE (Committee on Publication Ethics) to investigate and publish the results of the investigation, and retract the manuscripts for academic misconducts. Editors may even ask these authors to provide guarantees for the reliability of their research when they submit their manuscripts in the future, or issue a statement saying that the authors ’previous research reliability cannot be determined.

V. Retraction and Correction

Once the editorial department finds a publication error, it must be corrected or withdrawn in time. In dealing with publication ethics complaints, the editorial department will follow relevant national policies and procedures, follow the basic principles of Uniform Requirements for Submission of Biomedical Journals (http://www.icmje.org) formulated by ICMJE, and provide authors with a chance to respond. Regardless of whether the original manuscript has been published, all complaints must be strictly reviewed and relevant documents must be retained.

1. Author's voluntary retraction: After the online submission system successfully submits the manuscript, in the peer review process, due to special reasons to retract the manuscript, it is necessary to explain the situation to the editorial department. At the same time, the institution of author must provide instructions and affix the official seal, and the original or scanned copy should be sent to the editorial department for approval before the manuscript can be retracted. Once the manuscript is accepted by the editorial department, it cannot be retracted. If the manuscript is retracted twice in total, the editorial department will reject the manuscript as the first author or corresponding author within 1 year.

2. Retraction of editorial department: If the editorial department finds a serious error after the paper is published, it will publish a withdrawal declaration and refuse to accept its signed manuscript within 1 year, including the following situations: ① It has been confirmed that the paper has serious untrustworthiness, academic misconduct (including fabricate data and forge data) or non-subjective errors, so that the findings and results reported in the paper are not credible. ② The plagiarism problem exists in the paper. ③ The research reported in the paper violates medical ethics. ④ Repeat publication. ⑤ There are serious defects in the manuscript publishing process. If the manuscript has been officially published, the editorial department will publish a withdrawal declaration on the website and in the latest issue of journal, and send a withdrawal declaration to the relevant database collection agency to retract all data information of its manuscript.

3. Erratum / Correction: After publication, a small number of errors, such as data, charts, content, will be published in the latest issue of journal to correct the harmful effects of misleading publications.

Contact Us

Address: 207 Ruijin Er Rd., Shanghai 200025, China              

Tel: +86-21-54562376  

       +86-21-64377008*1305                                

Website: http://www.jsczz.cn

E-mail: zgjsczz@nipd.chinacdc.cn (new)

           zgjsczz@vip.163.com